TECH
Bio-Techne
$72.14
▲ +0.07%
+$0.05
NASDAQ · Healthcare · Biotechnology
· price updated 9h ago
Bio-Techne
TECH · NASDAQ · Healthcare · Biotechnology · price updated 9h ago
$72.14
▲ +0.07% · +$0.05 today
AI research · $72.14
Track TECH for continuous AI research
price position
Where TECH sits now
52-week range
Low$43.20
High$72.37
Today $72.14
RSI (14)
69.2Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$209.8M
Total debt$290.3M
Net cash after debt$-80.5M
Valuation
What the market charges
Forward P/E
Price against expected earnings
Needs attention · 93% above Sector avg
36.03x
Price / sales
Value assigned to each sales dollar
Rich · Above 8x annual sales
9.28x
Price / FCF
Price against free cash generation
Rich · Above 35x free cash flow
41.67x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
44.51x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
10.6%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
5.3%
Debt / equity
Balance-sheet leverage
Favorable · Exceptional vs sector peers
0.14x
Current ratio
Short-term assets against liabilities
Strong · Comfortable short-term liquidity
4.49x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How TECH compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $11.29B | 103.5 | +0.2% | 39 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Bio-Techne (TECH) stock
Bio-Techne — US core universe (S&P 500 sourced). TECH was +0.1% in the latest available session at $72.14. Its reported market value was $11.29B with a trailing P/E of 103.5. Latest reported revenue was $1.21B, changing +0.2% year over year, with $109.56M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $72.14
- Day change
- +0.1%
- Market cap
- $11.29B
- P/E (TTM)
- 103.5
- Revenue growth
- +0.2%
- Industry
- Biotechnology